Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2015
Dynamic allostery governs cyclophilin A-HIV capsid interplayManman Lu, Guangjin Hou, Huilan Zhang, et al.
Nature Communications|November 28, 2017
Quenching protein dynamics interferes with HIV capsid maturationMingzhang Wang, Caitlin M Quinn, Juan R Perilla, et al.
The Journal of Physical Chemistry. B|May 25, 2019
Dynamic Nuclear Polarization Magic-Angle Spinning Nuclear Magnetic Resonance Combined with Molecular Dynamics Simulations Permits Detection of Order and Disorder in Viral AssembliesRupal Gupta, Huilan Zhang, Manman Lu, et al.
The European Respiratory Journal|January 28, 2022
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiationYi Wang, Lei Zhang, Teng Huang, et al.
Cell Death and Differentiation|January 19, 2021
Kdm2a deficiency in macrophages enhances thermogenesis to protect mice against HFD-induced obesity by enhancing H3K36me2 at the Pparg locusLongmin Chen, Jing Zhang, Yuan Zou, et al.
Science Advances|December 5, 2020
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 programYi Wang, Lei Zhang, Guo-Rao Wu, et al.
Cell Death & Disease|November 27, 2019
Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarizationFaxi Wang, Fei Sun, Jiahui Luo, et al.
Cell Death and Differentiation|November 4, 2020
IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophagesLi-Zong Rao, Yi Wang, Lei Zhang, et al.
The Lancet. Oncology|November 9, 2025
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trialZan Hou, Baiqiang Dong, Qiwei Yao, et al.
Nature Communications|September 30, 2024
Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trialYumin Zhou, Fan Wu, Zhe Shi, et al.
Pageof 11